1. Home
  2. LFMD vs LRMR Comparison

LFMD vs LRMR Comparison

Compare LFMD & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$3.77

Market Cap

330.5M

Sector

Health Care

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.11

Market Cap

276.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
LRMR
Founded
1994
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
330.5M
276.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LFMD
LRMR
Price
$3.77
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$10.22
$16.71
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
03-09-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,091,814.00
N/A
Revenue This Year
$13.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.78
N/A
52 Week Low
$3.18
$1.61
52 Week High
$15.84
$5.37

Technical Indicators

Market Signals
Indicator
LFMD
LRMR
Relative Strength Index (RSI) 48.79 35.77
Support Level $3.84 $3.12
Resistance Level $4.36 $3.62
Average True Range (ATR) 0.25 0.21
MACD 0.04 -0.04
Stochastic Oscillator 42.21 1.10

Price Performance

Historical Comparison
LFMD
LRMR

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: